drugset / Trial / NCT02166177
Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients
Phase 1/2
Completed
9 enrolled
Guy's and St Thomas' NHS Foundation Trust
King's College London · collab
NaSingle-groupOpen-labelTreatment
Summary
'ThRIL' aims to explore the feasibility, safety and efficacy of TR002, a regulatory cell therapy, as adjunct immunosuppressive treatment in the context of liver transplantation
Timeline
- Start
- 2014-06
- Primary completion
- 2018-01-22
- Completion
- 2018-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous regulatory T Cell Product | Cell therapy | — | Intravenous |
| Background | Sirolimus | Small molecule | — | — |
| Background | Tacrolimus | Small molecule | — | — |
| Background | Thymoglobulin | Protein / enzyme biologic | — | — |